Veterinary Medicines

Nobilis Coryza Suspension for injection

Authorised
  • Avibacterium paragallinarum, serotype C, strain H18, Inactivated
  • Avibacterium paragallinarum, serotype B, strain Spross, Inactivated
  • Avibacterium paragallinarum, serotype A, strain 083, Inactivated
Download as PDF

Product identification

Medicine name:
Nobilis Coryza Suspension for injection
Nobilis Coryza
Active substance:
  • Avibacterium paragallinarum, serotype C, strain H18, Inactivated
  • Avibacterium paragallinarum, serotype B, strain Spross, Inactivated
  • Avibacterium paragallinarum, serotype A, strain 083, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Avibacterium paragallinarum, serotype C, strain H18, Inactivated
    1.00
    70% Protective Dose
    /
    0.25
    millilitre(s)
  • Avibacterium paragallinarum, serotype B, strain Spross, Inactivated
    1.00
    70% Protective Dose
    /
    0.25
    millilitre(s)
  • Avibacterium paragallinarum, serotype A, strain 083, Inactivated
    1.00
    70% Protective Dose
    /
    0.25
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID4) 500 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 500 millilitre(s)
  • (ID3) 500 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 500 millilitre(s)
  • (ID2) 250 millilitre(s): Box (Cardboard) with 1 Bottle (PolyEthylene TerePhthalate) with 250 millilitre(s)
  • (ID1) 250 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 250 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
  • Merck Sharp & Dohme Animal Health S.L.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.01765.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0261/001
Concerned member states:
  • Italy

Documents

Package Leaflet

English (PDF)
Published on: 7/02/2024
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/06/2024
Download